

1. How do we define the GTV of the primary head-and-neck tumor
& metastatic lymph node?
2. How do we define the CTV of the primary head-and-neck tumor
& metastatic lymph node?
3. What are organs-at-risk?
4. Do targets and OARs change during radiation therapy?
5. Do we need adaptive radiation therapy?
Questions